American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...

Around half a million Britons are now thought to be using the medication, which can help them lose up to 20 per cent of their ...

LBC can reveal the Advertising Standards Authority issued a warning to a weight loss treatment provider over an advert which ...

Telehealth company Hims & Hers' first Super Bowl ad is provocative and effective in building awareness of its weight loss ...

The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

Telehealth company Him & Hers Health is taking a very different approach to its Super Bowl ad this year - as its new ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with ...

Find out how Ozempic, Mounjaro, and other medicines are helping to revolutionise weight loss around the world... and how much ...

Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.